Streetbeat News

Products Services

IDYA

IDEAYA Biosciences is set to announce interim Phase 2 data for its drug darovasertib in treating uveal melanoma. The announcement will be made via a pre-market press release and an investor webcast on September 23, 2024. The webcast will cover clinical data, regulatory updates, and trial design.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:52 am

AGR

Avangrid CEO Pedro Azagra emphasized the urgency of climate action and highlighted the company's progress in clean energy at Climate Week NYC. Avangrid, part of the Iberdrola Group, is advancing the clean energy transition in the U.S. with over 9 GW of clean energy and the first large-scale offshore wind farm under construction.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:50 am

CNP

CenterPoint Energy is preparing for the 2024 hurricane season by monitoring weather forecasts and implementing its Greater Houston Resiliency Initiative. The company has installed stronger infrastructure and encourages customers to prepare emergency plans and enroll in their Power Alert Service for updates during outages.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:48 am

FFIE

Faraday Future has delivered an FF 91 2.0 Futurist Alliance vehicle to Born Leaders Entertainment at the Warwick Club in Hollywood on September 20.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:47 am

IPHA

Innate Pharma has received clearance from the US FDA for its IND application to start a Phase 1 clinical study of IPH4502, a Nectin-4 ADC, for solid tumors.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:47 am

SNX

Acronis partners with FC Bayern Basketball and TD SYNNEX to enhance IT infrastructure, aiming to expand its presence in Germany. This collaboration highlights the integration of top-tier technology with sports excellence.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:44 am

TEVA

Teva Pharmaceutical announced that a new analysis shows deutetrabenazine treatment leads to long-term improvement in Tardive Dyskinesia symptoms.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:44 am

AZN

Daiichi Sankyo and AstraZeneca's drug, datopotamab deruxtecan, did not achieve statistical significance in overall survival in a breast cancer trial, despite previous success in progression-free survival. The drug is being developed as a potential treatment option for metastatic breast cancer.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 6:42 am

GM

Unifor members at GM's CAMI Assembly and Battery Assembly plants in Ontario have ratified a new contract with significant pay increases. The contract includes a 15% wage increase for production workers and a 20.25% hike for skilled trades, expiring in 2026. This agreement supports workers during the transition to electric vehicles.

Portfolio Pulse from Anan Ashraf

September 23, 2024 | 6:21 am

BTCUSD

SOLUSD

Arthur Hayes, co-founder of BitMEX, expressed interest in Iggy Azalea's memecoin MOTHER due to favorable macroeconomic conditions. Bitcoin remained stable as the Japanese Yen weakened, prompting Hayes to consider trading meme coins. The MOTHER token, based on Solana, has grown significantly since its launch.

Portfolio Pulse from Aniket Verma

September 23, 2024 | 6:19 am